Related Experiment Videos
Phosphorylation of TRAF2 inhibits binding to the CD40 cytoplasmic domain
1Mucosal Immunology Laboratory, Combined Program in Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital, Charlestown, Massachusetts, 02129, USA.
Abstract:
TRAF2 is a signal transducing adaptor molecule which binds to the CD40 cytoplasmic domain. We have found that it is phosphorylated, predominantly on serine residues, when transiently overexpressed in 293 cells. The phosphorylation appears to be related to the signaling events that are activated by TRAF2 under these circumstances, since two nonfunctional mutants were found to be phosphorylated significantly less than the wild-type protein. Furthermore, the phosphorylation status of TRAF2 had significant effects on the ability of the protein to bind to CD40, as evidenced by our observations that the CD40 cytoplasmic domain interacted preferentially with underphosphorylated TRAF2 and that phosphatase treatment significantly enhanced the binding of TRAF2 to CD40. We conclude from these studies that the phosphorylation of TRAF2 is likely to play an important role in regulating signaling by virtue of its ability to influence the CD40-TRAF2 interaction.
Insights
Phosphorylation of Tumor necrosis factor receptor-associated factor 2 (TRAF2) regulates its binding to CD40. This phosphorylation status influences TRAF2
Area of Science:
- Molecular Biology
- Immunology
- Cell Signaling
Background:
- Tumor necrosis factor receptor-associated factor 2 (TRAF2) is a key signal-transducing adaptor protein.
- TRAF2 interacts with the cytoplasmic domain of CD40, a critical receptor in immune responses.
- The precise regulatory mechanisms of TRAF2's function in CD40 signaling remain incompletely understood.
Purpose of the Study:
- To investigate the role of TRAF2 phosphorylation in its interaction with CD40.
- To determine how TRAF2's phosphorylation status affects CD40-mediated signaling.
Main Methods:
- Transient overexpression of wild-type and mutant TRAF2 in 293 cells.
- Analysis of TRAF2 phosphorylation, predominantly on serine residues.
- Assessment of TRAF2 binding to the CD40 cytoplasmic domain.
- Treatment with phosphatases to evaluate dephosphorylation effects.
Main Results:
- TRAF2 is phosphorylated on serine residues upon overexpression.
- Nonfunctional TRAF2 mutants exhibit reduced phosphorylation compared to wild-type.
- Underphosphorylated TRAF2 preferentially binds to the CD40 cytoplasmic domain.
- Phosphatase treatment enhances TRAF2 binding to CD40.
Conclusions:
- TRAF2 phosphorylation is a critical regulatory mechanism for its interaction with CD40.
- The phosphorylation status of TRAF2 directly influences its ability to bind CD40.
- This modulation of the CD40-TRAF2 interaction is likely important for regulating downstream signaling events.